As reported in the Marine Times, the Army Times, and the Air Force Times, the VA proposed substituting early-onset peripheral neuropathy for acute and subacute neuropathy on its lists of... read more →
Janssen Pharmaceuticals, Inc. announced the FDA has approved the supplemental New Drug Application for NUCYNTA ER extended-release tables for the management of neuropathic pain associated with diabetic peripheral neuropathy. NUCYNTA... read more →
The American Chronic Pain Society joined with Pfizer to conduct a survey on the prevalence of symptoms of diabetic peripheral neuropathy in patients with diabetes. Their results show that nerve pain... read more →
Two clinical trials, one in the US and one in China have been completed on the results of taking Acetyl-l-Carnitine, either during chemotherapy treatments or before treatment. With very different results presented... read more →
First published online by BioMed Central, researchers from Tehran and Tabriz Universities, Iran, have found that Omega-3 fatty acids have beneficial effects on neurological disorders from the side effects of... read more →